Viagra is Safe for Patients with Open-Angle Glaucoma
Sildenafil (Viagra) does not pose a clinically significant risk of worsening vision or glaucoma progression in patients with open-angle glaucoma and can be safely prescribed for erectile dysfunction. The FDA label notes that patients should inform their doctor if they have "severe vision loss" or retinitis pigmentosa, but does not contraindicate use in open-angle glaucoma 1.
Evidence Supporting Safety
No Effect on Intraocular Pressure
Multiple controlled studies demonstrate that sildenafil does not cause clinically meaningful changes in IOP:
A randomized, double-blind, placebo-controlled crossover study of 15 patients with bilateral chronic open-angle glaucoma found no statistically or clinically significant change in IOP after a single 100 mg dose of sildenafil (P=0.20), with measurements taken hourly for 5 hours post-dose 2.
Studies in healthy volunteers receiving doses ranging from 10-150 mg showed no major changes in IOP at any time point from 1-24 hours after administration 3.
Review of 36 subjects with a medical history of increased IOP in the sildenafil safety database found none had clinically significant IOP increases 3.
Potential Protective Association
Recent large-scale observational data suggest an unexpected finding:
A multicenter retrospective cohort study using propensity score matching found that chronic PDE-5 inhibitor use was associated with a lower hazard of developing glaucoma suspect status and open-angle glaucoma at 1,2, and 3 years (adjusted HR 0.84 for OAG at 3 years; 95% CI 0.79-0.88; P=0.01) 4.
This protective association remained consistent across multiple sensitivity analyses 5.
Mechanism and Visual Side Effects
Why Sildenafil is Safe in Open-Angle Glaucoma
Sildenafil works by inhibiting PDE5, which increases cGMP levels and causes smooth muscle relaxation in the corpus cavernosum 1. While it has minor inhibitory action against PDE6 (found in retinal photoreceptors), this cross-reactivity causes only transient, reversible visual symptoms in a minority of patients at higher doses 6.
Expected Transient Visual Effects (Not Related to Glaucoma)
The most common visual side effects are mild and temporary 1, 6:
- Blue tinge to vision or difficulty distinguishing blue from green
- Increased brightness of lights
- Mild blurred vision
- Increased light sensitivity
These effects occur around peak plasma levels (30-120 minutes post-dose) and resolve within hours. They are related to PDE6 inhibition in photoreceptors, not to changes in IOP or optic nerve damage 6.
Choroidal Effects Without IOP Impact
Sildenafil increases choroidal blood flow and thickness through vasodilation 7. While earlier theories suggested this might increase IOP via a "parallel pathway" from increased choroidal volume, clinical studies have not demonstrated sustained or clinically significant IOP elevations 7, 5.
Important Caveats
Contraindications That Matter
The FDA label clearly states sildenafil should never be used with nitrates (for angina/chest pain) due to risk of severe hypotension 1. Other important considerations:
- Patients with history of stroke, heart attack, or severe cardiovascular disease require careful evaluation
- Dose adjustment needed for severe liver/kidney disease or when taking protease inhibitors
- Alpha-blocker users (for prostate/hypertension) may need lower starting doses due to blood pressure effects 1
Rare Serious Visual Events (Not Glaucoma-Related)
The FDA label warns about rare instances of:
- Sudden vision loss (NAION - non-arteritic ischemic optic neuropathy): Stop medication immediately and seek urgent ophthalmologic evaluation 1, 8
- Central serous retinopathy: Related to effects on retinal perfusion, not glaucoma 8
These events are not related to glaucoma progression and occur in patients with or without pre-existing glaucoma.
Clinical Recommendation
You can safely prescribe sildenafil to this patient with open-angle glaucoma. Counsel him that:
- Transient color vision changes (blue tinge) or increased light sensitivity may occur but are harmless and temporary
- He should stop the medication and seek immediate care if he experiences sudden vision loss in one or both eyes (different from his glaucoma)
- The medication will not worsen his glaucoma or increase his eye pressure
- He should continue his regular glaucoma monitoring schedule as previously established
The standard starting dose is 50 mg taken approximately 1 hour before sexual activity, with dose adjustment based on efficacy and tolerability 1. Ensure he is not taking nitrates and review his cardiovascular status before prescribing.